Clinical Trial For Experimental Ebola Treatment Halted In Liberia For Lack Of Patients

Agence France-Presse: Low infection rate halts Ebola treatment trials in Liberia
“Britain’s Wellcome Trust said that clinical trials it was funding for a new Ebola treatment in Liberia were halted on Tuesday due to a fall in new cases. … The Wellcome Trust said the decision was taken on Tuesday after the pharmaceutical company Chimerix, which manufactures the brincidofovir treatment, said it was withdrawing from the trial on Friday…” (2/4).